


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.11%
-1.71%
+0.19%
+0.11%
-0.01%
CVS
CVS Health
$75.70
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
CVS Price Performance
$79.33 (-4.58%)
$77.83 (-2.74%)
$74.42 (+1.72%)
$64.48 (+17.40%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CVS Street Sentiment is bullish but have mixed views on the near-term outlook
CVS has Low risk level
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Dec 18, 2025
Reiterate
Overweight
JP Morgan
Dec 10, 2025
Reiterate
Outperform
Baird
Dec 10, 2025
Reiterate
Outperform
Mizuho
Dec 10, 2025
Reiterate
Overweight
Cantor Fitzgerald
Dec 10, 2025
Reiterate
Overweight
Morgan Stanley
What is CVS current stock price?
What are CVS stock strengths?
What is CVS Risk Level?
What is CVS market cap and volume?
What is CVS current Stock IQ?
Should I buy CVS stock right now?
Is CVS a Strong Buy right now?
What does a 'Strong Buy' rating mean for CVS?
What does a 'Strong Sell' rating mean for CVS?
What factors influence CVS's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.11%
-1.71%
+0.19%
+0.11%
-0.01%
CVS
CVS Health
Current Price
$75.70

CVS Price Performance
$79.33 (-4.58%)
$77.83 (-2.74%)
$74.42 (+1.72%)
$64.48 (+17.40%)
CVS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CVS Street Sentiment is bullish but have mixed views on the near-term outlook
CVS has Low risk level
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 18, 2025
Reiterate
Overweight
JP Morgan
Dec 10, 2025
Reiterate
Outperform
Baird
Dec 10, 2025
Reiterate
Outperform
Mizuho
Dec 10, 2025
Reiterate
Overweight
Cantor Fitzgerald
Dec 10, 2025
Reiterate
Overweight
Morgan Stanley
CVS Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
CVS Latest Analysis
CVS Health Reaffirms Profit Outlook After Q4 Beat. CVS) on Tuesday reported fourth-quarter fiscal 2025 results.The company reported sales of $105.69 billion beating the. Total revenues increased 8.2% year-over-year driven by revenue growth across all segments.Adjusted earnings of $1.09per share also beat the analyst estimate of 99 cents decreased from $1.19 in the prior year primarily due to a decline in adjusted operating income in the Health Care Benefits segment reflecting changes in the seas
Tue Feb 10, 2026
CVS Lets Down Wall Street With Reaffirmed Profit Guidance. CVS Health Corp. disappointed Wall Street by reiterating its profit guidance for 2026 a move analysts are calling a letdown after a strong fourth-quarter performance.
Tue Feb 10, 2026
Jim Cramer on Coca-Colas Retiring CEO: He Will Be missed. The Coca-Cola Company (NYSE:KO) is one of the stocks in focus on Jim Cramers game plan. Cramer noted the CEOs retirement as he commented:On Tuesday were back in heavy earnings rotation. Weve got DuPont Coca-Cola CVS Health AstraZeneca Datadog and S&.P Global report PepsiCo stock went
Tue Feb 10, 2026
The CVS Earnings Bombshell That Has Investors Scrambling Right Now. Quick Read CVS Health (CVS) beat Q4 revenue expectations at $105.69B. Adjusted earnings fell to $1.09 from $1.19 prior year. CVSs Health Care Benefits segment posted a $676M operating loss and shed 504000 members year-over-year. CVS reduced 2026 operating cash flow guidance to
Tue Feb 10, 2026
Earnings Snapshot: CVS Health tops Q4 expectations but FY2026 outlook disappoints.
Tue Feb 10, 2026
CVS Health drops despite Q4 beat amid in-line guidance.
Tue Feb 10, 2026
CVS Health in Charts: Q4 Health Care Benefits revenue up 10% Y/Y. Pharmacy grows 12%.
Tue Feb 10, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.